A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
The DOI matches its Crossref record.
Abstract
BACKGROUND: More treatment options for bipolar depression are needed. Currently available antidepressants may increase the risk of mania and rapid cycling, and mood stabilizers appear to be less effective in treating depression than mania. Preliminary data suggest that lamotrigine, an established antiepileptic drug, may be effective for both the depression and mania associated with bipolar disorder. This is the first controlled multicenter study evaluating lamotrigine monotherapy in the treatment of bipolar I depression. METHODS: Outpatients with bipolar I disorder experiencing a major depressive episode (DSM-IV, N = 195) received lamotrigine (50 or 200 mg/day) or placebo as monotherapy for 7 weeks. Psychiatric evaluations, including the Hamilton Rating Scale for Depression (HAM-D), the Montgomery-Asberg Depression Rating Scale (MADRS), Mania Rating Scale, and the Clinical Global Impressions scale for Severity (CGI-S) and Improvement (CGI-I) were completed at each weekly visit. RESULTS: Lamotrigine 200 mg/day demonstrated significant antidepressant efficacy on the 17-item HAM-D, HAM-D Item 1, MADRS, CGI-S, and CGI-I compared with placebo. Improvements were seen as early as week 3. Lamotrigine 50 mg/day also demonstrated efficacy compared with placebo on several measures. The proportions of patients exhibiting a response on CGI-I were 51%, 41%, and 26% for lamotrigine 200 mg/day, lamotrigine 50 mg/day, and placebo groups, respectively. Adverse events and other safety results were similar across treatment groups, except for a higher rate of headache in the lamotrigine groups. CONCLUSION: Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while clinical experience and the results of many studies suggest that response to mood stabilizers and antipsychotics is similar in BDII and BDI, there are enough exceptions to suggest this should not be taken for granted.248, 405, 431”
Citations
Cites
Still being checked.
Cited by
Items 401–500 of 1,000
Lamotrigine: a depression mood stabiliser
HERMAN, E. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.03.003 · Cited by 25
Singh, J. B., Zarate, C. A., & Krystal, A. D. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1756-8 · Cited by 25
Effectiveness of lamotrigine in bipolar disorder in a clinical setting
Ketter, T. A., Brooks, J. O., Hoblyn, J. C., Champion, L. M., Nam, J. Y., Culver, J. L., Marsh, W., & Bonner, J. C. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.02.007 · Cited by 27
Lamotrigine as a mood stabilizer: insights from the pre-clinical evidence
de Miranda, A. S., de Miranda, A. S., & Teixeira, A. L. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1553951 · Cited by 24
Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines
Jeong, J., Bahk, W., Woo, Y. S., Lee, J. G., Kim, M.-D., Sohn, I., Shim, S.-H., Jon, D., Seo, J. S., Kim, W. K., et al. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.2.155 · Cited by 25
A Clinician's Guide to Statistics and Epidemiology in Mental Health: Measuring Truth and Uncertainty
Ghaemi, S. N. (2009) · Cited by 25
Bipolar II and the bipolar spectrum
Skeppar, P., & Adolfsson, R. (2006) · Nordic Journal of Psychiatry · doi:10.1080/08039480500504685 · Cited by 24
Anticonvulsivantes e antipsicóticos no tratamento do transtorno bipolar
Moreno, R. A., Moreno, D. H., Soares, M. B. D. M., & Ratzke, R. (2004) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462004000700009 · Cited by 61
Treatment of Bipolar Depression
Dubovsky, S. L. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.02.003 · Cited by 25
Antiepileptic Drugs and Mood Stability
Amann, B. L., Grunze, H., Vieta, E., & Trimble, M. (2007) · Clinical EEG and Neuroscience · doi:10.1177/155005940703800214 · Cited by 27
Walpoth, M., Kemmler, G., Grunze, H., Wei, U., Hörtnagl, C., Strau, R., Blasko, I., & Hausmann, A. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328356ac92 · Cited by 28
Role of lamotrigine in the management of treatment-resistant bipolar II depression: A chart review
Sharma, V., Khan, M., & Corpse, C. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.029 · Cited by 25
Lack of Pharmacokinetic Interaction Between Lamotrigine and Olanzapine in Healthy Volunteers
Jann, M. W., Hon, Y. Y., Shamsi, S. A., Zheng, J., Awad, E. A., & Spratlin, V. E. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.5.627 · Cited by 25
Schüle, C., Baghai, T. C., Eser, D., Nothdurfter, C., & Rupprecht, R. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701849978 · Cited by 24
Sackellares, J. C., Kwong, W. J., Vuong, A., Hammer, A. E., & Barrett, P. S. (2002) · Epilepsy & Behavior · doi:10.1016/s1525-5050(02)00046-x · Cited by 28
Matching the Bipolar Patient and the Mood Stabilizer
Gelenberg, A. J., & Pies, R. W. (2003) · Annals of Clinical Psychiatry · doi:10.1023/b:acli.0000008174.46414.a4 · Cited by 27
Pharmacological interventions for bipolar youth: Developmental considerations
DelBello, M. P., & Kowatch, R. A. (2006) · Development and Psychopathology · doi:10.1017/s0954579406060597 · Cited by 26
Lamotrigine plus Quetiapine Combination Therapy in Treatment-Resistant Bipolar Depression
Ahn, Y. M., Nam, J. Y., Culver, J. L., Marsh, W. K., Bonner, J. C., & Ketter, T. A. (2011) · Annals of Clinical Psychiatry · doi:10.1177/104012371102300104 · Cited by 23
Samalin, L., Guillaume, S., Courtet, P., Abbar, M., Lancrenon, S., & Llorca, P. (2012) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2012.10.001 · Cited by 23
Treatment-Resistant Depression in Adolescents: Recognition and Management
Brent, D. A., & Birmaher, B. B. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2006.05.001 · Cited by 27
Bipolar depression: a new role for atypical antipsychotics?
Keck, P. E. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00213.x · Cited by 23
Historical Review of Carbamazepine for the Treatment of Bipolar Disorder
Stoner, S. C., Nelson, L. A., Lea, J. W., Marken, P. A., Sommi, R. W., & Dahmen, M. M. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.1.68 · Cited by 23
The Use of Topiramate in Mood Stabilization
Maidment, I. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a398 · Cited by 23
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP‐BD
Marangell, L. B., Martinez, J. M., Ketter, T. A., Bowden, C. L., Goldberg, J. F., Calabrese, J. R., Miyahara, S., Miklowitz, D. J., Sachs, G. S., Thase, M. E., et al. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00098.x · Cited by 23
Self-citationVEGF regulates antidepressant effects of lamotrigine
Sun, R., Li, N., & Li, T. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.010 · Cited by 22
The Black Book of Psychotropic Dosing and Monitoring
DeBattista, C., & Schatzberg, A. F. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4493 · Cited by 25
Moore, J. L., & Aggarwal, P. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.665875 · Cited by 24
An overview of pharmacotherapy for bipolar I disorder
Morsel, A., Morrens, M., & Sabbe, B. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1426746 · Cited by 24
Evaluating the efficacy and safety of antidepressants in patients with bipolar disorder
Cheniaux, E., & Nardi, A. E. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1651291 · Cited by 26
Tolerability and Effectiveness of Lamotrigine in Complex Elderly Patients
Aulakh, J. S., Hawkins, J. W., Athwal, H. S., Sheikh, J. I., Yesavage, J. A., & Tinklenberg, J. R. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704271762 · Cited by 23
Prophylaxis of bipolar disorder: how and who should we treat in the long term?
Goodwin, G. M. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00026-7 · Cited by 22
Major advances in bipolar disorder
Mitchell, P. B., Malhi, G. S., & Ball, J. R. B. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06238.x · Cited by 24
When Do Antidepressants Worsen the Course of Bipolar Disorder?
Goldberg, J. F. (2003) · Journal of Psychiatric Practice · doi:10.1097/00131746-200305000-00002 · Cited by 22
Muck-Seler, D., Sagud, M., Mustapic, M., Nedic, G., Babic, A., Mihaljevic Peles, A., Jakovljevic, M., & Pivac, N. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.03.004 · Cited by 21
“…data imply that antiepileptic drug lamotrigine (3,5- diamino-6-(2,3-dichlorphenyl)-1,2,4-triazine) could be also effective in the treatment of depression (Calabrese et al., 1999; Goldsmith et al., 2003) and in prevention of relapse (Calabrese et al., 2003) in patients with bipolar disorder.”
BackgroundCheng, C., Chang, W. H., Lin, Y., Chen, P. S., Yang, Y. K., & Bai, Y. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103480 · Cited by 24
Safety and Efficacy of Quetiapine in Bipolar Depression
Bogart, G. T., & Chavez, B. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m193 · Cited by 26
Is it safe to use lamotrigine during pregnancy? A prospective comparative observational study
Diav‐Citrin, O., Shechtman, S., Zvi, N., Finkel‐Pekarsky, V., & Ornoy, A. (2017) · Birth Defects Research · doi:10.1002/bdr2.1058 · Cited by 23
Wang, D., & Osser, D. N. (2019) · Bipolar Disorders · doi:10.1111/bdi.12860 · Cited by 23
Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine
Large, C. H., Daniel, E. D., Li, X., & George, M. S. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371080 · Cited by 22
The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders
Bourin, M., & Prica, C. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.03.001 · Cited by 25
Goldberg, J. F., Calabrese, J. R., Saville, B. R., Frye, M. A., Ketter, T. A., Suppes, T. M., Post, R. M., & Goodwin, F. K. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04381 · Cited by 22
Self-citationClass effect of pharmacotherapy in bipolar disorder: fact or misbelief?
Fountoulakis, K. Ν., Gonda, X., Vieta, E., & Rihmer, Z. (2011) · Annals of General Psychiatry · doi:10.1186/1744-859x-10-8 · Cited by 23
La place des antipsychotiques atypiques dans le traitement des syndromes dépressifs
Quintin, P., & Thomas, P. (2004) · L Encéphale · doi:10.1016/s0013-7006(04)95474-7 · Cited by 28
Hypomania Induced by Adjunctive Lamotrigine
Margolese, H. C., Beauclair, L., Szkrumelak, N., & Chouinard, G. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.183-a · Cited by 21
Manning, J. S., Haykal, R. F., Connor, P. D., Cunningham, P. D., Jackson, W., & Long, S. R. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.01.016 · Cited by 21
Adverse psychiatric effects of antiepileptic drugs
Gilliam, F. G., & Santos, J. M. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.09.024 · Cited by 21
What makes a drug a primary mood stabilizer?
Keck, P. E., McElroy, S. L., Richtand, N. M., & Tohen, M. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001013 · Cited by 23
Concepts in the treatment of bipolar disorder
Greil, W., & Kleindienst, N. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s418.9.x · Cited by 21
Acute and prophylactic effects of anticonvulsants in bipolar depression
Post, R. M., Speer, A. M., Obrocea, G. V., & Leverich, G. S. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00047-6 · Cited by 20
A factor analytic study in bipolar depression, and response to lamotrigine
Mitchell, P. B., Hadzi-Pavlovic, D., Evoniuk, G., Calabrese, J. R., & Bowden, C. L. (2013) · CNS Spectrums · doi:10.1017/s1092852913000291 · Cited by 20
Self-citationA systematic review of the evidence for the treatment of acute depression in bipolar I disorder
Cerullo, M. A., & Strakowski, S. M. (2013) · CNS Spectrums · doi:10.1017/s1092852913000102 · Cited by 21
General Anesthetics to Treat Major Depressive Disorder: Clinical Relevance and Underlying Mechanisms
Vutskits, L. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002594 · Cited by 25
Lamotrigine (Lamictal IR) for the treatment of bipolar disorder
Bowden, C. L., & Singh, V. K. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.741590 · Cited by 20
Self-citationUse and safety of antiepileptic drugs in psychiatric inpatients—data from the AMSP study
Druschky, K., Bleich, S., Grohmann, R., Engel, R. R., Kleimann, A., Stübner, S., Greil, W., & Toto, S. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0827-5 · Cited by 20
Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder
Grunze, H., & Walden, J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00339-7 · Cited by 20
Chronic Depression in Bipolar Disorder
El‐Mallakh, R. S., & Karippot, A. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.8.1337 · Cited by 22
An Association of Intrusive, Repetitive Phrases with Lamotrigine Treatment in Bipolar II Disorder
Kemp, D. E., Gilmer, W. S., Fleck, J., & Dago, P. L. (2007) · CNS Spectrums · doi:10.1017/s1092852900020617 · Cited by 20
Lamotrigine: Pharmacology, Clinical Utility, and New Safety Concerns
Mufson, J. (2018) · American Journal of Psychiatry Residents Journal · doi:10.1176/appi.ajp-rj.2018.131201 · Cited by 20
Current Discoveries on the Cognitive Effects of Antiepileptic Drugs
Meador, K. J. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.12.185s.35253 · Cited by 19
Bai, Y., Yang, H., Chen, G., & Gao, K. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001169 · Cited by 21
Woo, Y. S., Bahk, W., Jon, D., Joo, Y. H., Kim, W. K., Seo, J. S., Ahn, Y. M., Chung, S., Won, S., Shin, Y. C., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.010 · Cited by 19
Bipolar II Disorder: Current and Future Treatment Options
El‐Mallakh, R. S., Weisler, R. H., Townsend, M. H., & Ginsberg, L. D. (2006) · Annals of Clinical Psychiatry · doi:10.1080/10401230600948480 · Cited by 18
Garza, R. D. L., Jentsch, J. D., Verrico, C. D., & Roth, R. H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03772-1 · Cited by 20
Treatment of Psychotic Symptoms With Lamotrigine in Alzheimer Disease
León, O. A. D. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000117431.83724.b0 · Cited by 18
New Anticonvulsant Medication Uses in Bipolar Disorder
Wang, P. W., Ketter, T. A., Becker, O. V., & Nowakowska, C. (2003) · CNS Spectrums · doi:10.1017/s1092852900028704 · Cited by 19
Special issues in trial design and use of placebo in bipolar illness
Post, R. M., Denicoff, K. D., & Leverich, G. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00315-7 · Cited by 19
Treatment of bipolar affective disorder
Young, A. H., Macritchie, K., & Calabrese, J. R. (2000) · BMJ · doi:10.1136/bmj.321.7272.1302 · Cited by 18
Self-citationWang, G., Wang, J., He, D., Li, X., Li, J., & Peng, Z.-Y. (2016) · Heterocycles · doi:10.3987/com-16-13491 · Cited by 17
Feasibility of a slower lamotrigine titration schedule for bipolar depression: a naturalistic study
Joe, S. H., Chang, J. S., Won, S., Rim, H.-D., Ha, T. H., & Ha, K. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32832775fe · Cited by 18
Management of obsessive-compulsive disorder comorbid with bipolar disorder
Kazhungil, F., & Mohandas, E. (2016) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.192001 · Cited by 19
Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., McElroy, S. L., Keck, P. E., Kupka, R., Denicoff, K. D., Nolen, W. A., Grunze, H., et al. (2007) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.5.1.98 · Cited by 17
The management of bipolar disorder in primary care: A review of existing and emerging therapies
BERK, M., Dodd, S., & Berk, L. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01365.x · Cited by 21
Complex partial seizures and depression
Greenlee, B. A., Ferrell, R. B., Kauffman, C. I., & McAllister, T. W. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0076-3 · Cited by 18
Kasper, S. F. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.6.s9 · Cited by 19
Pharmacotherapy for bipolar depression: an economic assessment
Bowden, C. L., & Krishnan, A. A. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.5.1101 · Cited by 19
Self-citationTreatment of acute bipolar depression
Shen, Y. (2018) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_71_18 · Cited by 21
Lamotrigine and Clozapine for Bipolar Disorder
Calabrese, J. R., & Gajwani, P. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1523 · Cited by 17
Self-citationKumar, R., Nuñez, N. A., Prokop, L. J., Veldic, M., Betcher, H., & Singh, B. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001475 · Cited by 16
Schoenknecht, P., Traenkner, & Sander (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s37126 · Cited by 16
Ion Channels and Their Inhibitors
Gupta, S. P. (2011) · Springer eBooks · doi:10.1007/978-3-642-19922-6 · Cited by 18
The Multiple Facets of Treatment-Resistant Depression
Souery, D., & der Auwera, K. V. (2004) · CNS Spectrums · doi:10.1017/s1092852900002224 · Cited by 16
Pharmacological Therapies in Bipolar Disorder: a Review of Current Treatment Options.
Joshi, A., Bow, A., & Agius, M. (2019) · PubMed · Cited by 35
Ansari, A., & Osser, D. N. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673220903523524 · Cited by 20
Comparative bioethics in bipolar and epilepsy research
Kaufman, K. R. (2002) · Seizure · doi:10.1053/seiz.2001.0585 · Cited by 16
Maintenance therapy for bipolar disorder: current and future management options
Vieta, E. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.6.s35 · Cited by 18
Bipolar depression: a review of randomised clinical trials
Goodnick, P. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.1.13 · Cited by 17
Clinical Relevance and Treatment Possibilities of Bipolar Rapid Cycling
Grunze, H., Amann, B. L., Dittmann, S., & Walden, J. (2002) · Neuropsychobiology · doi:10.1159/000049257 · Cited by 16
Knoester, P. D., Belitser, S. V., Deckers, C. L. P., Keyser, A., Renier, W. O., Egberts, T. C. G., & Hekster, Y. A. (2004) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2004.00544.x · Cited by 16
Shim, S., Mansari, M. E., & Blier, P. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.203315 · Cited by 16
Lamotrigine in Psychiatry: Pharmacology and Therapeutics
Jefferson, J. W. (2005) · CNS Spectrums · doi:10.1017/s1092852900010063 · Cited by 18
Goldberg, J. F. (2000) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(05)70119-x · Cited by 15
Current treatments for bipolar disorder: A review and update for psychologists.
Rivas-Vazquez, R. A., Johnson, S. L., Rey, G. J. F. D., Blais, M. A., & Rivas-Vazquez, A. A. (2002) · Professional Psychology Research and Practice · doi:10.1037//0735-7028.33.2.212 · Cited by 17
Depressive subtypes and efficacy of antidepressive pharmacotherapy
Ayuso-Gutiérrez, J. L. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510030036 · Cited by 17
Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach
Thase, M. E., Bhargava, M., & Sachs, G. S. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00029-7 · Cited by 17
Self-citationChoroideremia: The Endpoint Endgame
Elsayed, M. E. A. A., Taylor, L. J., Josan, A. S., Fischer, M. D., & MacLaren, R. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814354 · Cited by 17
Parker, G. B., & McCraw, S. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12427 · Cited by 14
Grande, I., Balanzá‐Martínez, V., Jiménez-Arriero, M., Lorenzo, F. G. I., Valverde, J. I. F., de Arce, R., Domingo, S. Z., Cobaleda, S., & Vieta, E. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.035 · Cited by 15
Young, A. H. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2316 · Cited by 14
Treatment of recurrent depression
Greden, J. F. (2001) · Cited by 26
Newer Anticonvulsant Drugs in Neuropathic Pain and Bipolar Disorder
Chandramouli, J. C. (2002) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v16n04_03 · Cited by 14
Metadata
- Authors
- Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group
- Affiliations
- Case Western Reserve University (US)
- GlaxoSmithKline (United Kingdom) (GB)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-02-15
- Volume
- 60
- Issue
- 2
- Pages
- 79-88
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2058120764
- Cited by
- 1,054
- References
- 0
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 15 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 162 · 2019: 10 · 2018: 13 · 2017: 13 · 2016: 13 · 2015: 18 · 2014: 23 · 2013: 24 · 2012: 34
- FWCI
- 47.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- lamotrigine, bipolar I depression, bipolar disorder, antidepressant monotherapy, antiepileptic drugs, major depressive episode, treatment response, adverse events, headache, drug tolerability
- MeSH terms
- Lamotrigine, Adult, Aged, Ambulatory Care, Anticonvulsants, Bipolar Disorder, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Patient Compliance, Placebos, Psychiatric Status Rating Scales, Severity of Illness Index, Triazines, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.